FT
Full-Life Technologies
China · Biotech · Healthtech
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D+Debt | $150M | Chengwei Capital — Role not disclosedHSG — Role not disclosedJunson Capital — Role not disclosedPlaisance — Role not disclosedSK Biopharmaceuticals Co. Ltd. — Role not disclosedSky9 Capital — Role not disclosedTSG Capital — Role not disclosedVivo Capital — Role not disclosedYunion — Role not disclosed |